Furthermore, MSH2 negative staining was significantly more frequent in low-grade astrocytomas (45%) than in high-grade astrocytomas (16%) (P=0.012), whereas MLH1 and MSH6 expression were not associated with tumor histopathology (Table 2). Here, MSH2 is linked to astrocytoma (excluding glioblastoma).